Treatment of BRL 28500 (clavulanic acid-ticarcillin) for infections in patients with hematological diseases

Keisuke Toyama, Shinichiro Okamoto, Hiroshi Uchida, Yasuhiko Ando

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Treatment of BRL 28500 (clavulanic acid-ticarcillin) for infections in patients with hematological diseases'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences